(Q38848770)

English

miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases

scientific article published on 24 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases (English)

1 reference

Europe PubMed Central

7 September 2017

author name string

Bo Qu

1

1 reference

Europe PubMed Central

7 September 2017

Xun Xia

2

1 reference

Europe PubMed Central

7 September 2017

Ming Yan

3

1 reference

Europe PubMed Central

7 September 2017

Kai Gong

4

1 reference

Europe PubMed Central

7 September 2017

Shaolin Deng

5

1 reference

Europe PubMed Central

7 September 2017

Gang Huang

6

1 reference

Europe PubMed Central

7 September 2017

Zehui Ma

7

1 reference

Europe PubMed Central

7 September 2017

Xianming Pan

8

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

24 July 2015

1 reference

Europe PubMed Central

7 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

7 September 2017

338

1 reference

Europe PubMed Central

7 September 2017

1

1 reference

Europe PubMed Central

7 September 2017

89-96

1 reference

Europe PubMed Central

7 September 2017

Osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Cell biology of the osteoclast

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Regulation of microRNA function in somatic stem cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

MicroRNA functions in osteogenesis and dysfunctions in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

The role of microRNAs in osteoclasts and osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

MiR-503 regulates osteoclastogenesis via targeting RANK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

MicroRNAs modulate the Wnt signaling pathway through targeting its inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Rho GTPases in osteoclasts: orchestrators of podosome arrangement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

The osteoclast, bone remodelling and treatment of metabolic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Osteoclast-derived coupling factors in bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Cell-tethered ligands modulate bone remodeling by osteoblasts and osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Rankl-induced osteoclastogenesis leads to loss of mineralization in a medaka osteoporosis model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Osteocyte RANKL: new insights into the control of bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

OA-4 inhibits osteoclast formation and bone resorption via suppressing RANKL induced P38 signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.07.023

7 January 2021

Identifiers

10.1016/J.YEXCR.2015.07.023

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38848770&oldid=1790221637"